ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial (Q64694116)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial |
clinical trial |
Statements
ODiXaHip (English)
0 references
Oral Direct Factor Xa Inhibitor BAY 59-7939 in the Prevention of VTE in Patients Undergoing Total Hip Replacement. ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial (English)
0 references
December 2002
0 references
November 2003
0 references
641
0 references
18 year
0 references